S&P 500 Falls as Investors Get Spooked by High Costs of AI
Compared to the previous week, the S&P 500 (Index: SPX) didn’t change much in the trading week ending on Friday, 30 October 2026. The index closed out the week at 7,580.07, down a little under 0.6% from where it closed the preceding week.
But that doesn’t quite capture what happened. Stock prices rose the first three days of the week. And then, after the bell on Wednesday, 28 September 2026, tech giant Alphabet (NASDAQ: GOOG and GOOGL) reported not just that they were burning through cash to build up their Artificial Intelligence (AI) infrastructure, their advertising revenue from Internet searches was lower than expected, as their AI-based search feature underperformed expectations.
That was enough to deflate the company’s stock by 12% on Thursday, 29 October 2026, which in turn, contributed to pulling the S&P 500 down by 0.3% for the day. But then after the market closed on Thursday, Amazon (NASDAQ: AMZN) and Intel (NASDAQ: INTC) delivered bad news of higher costs and falling revenues.
Of the two, Intel had the worst of it, with its stock plunging by over 28% by the time markets closed on Friday. More significantly, their combined bad news prompted investors to tank the stock prices of other chipmakers. Including the biggest company in the S&P 500, Nvidia (NASDAQ: NVDA), which lost over 4% of its value and became the second-biggest company in the index as a result by the end of the day.
By the end of the day, the S&P 500 lost over 1.8% of its total value. The latest update of the alternative futures chart shows the index’ trajectory dropped to be near the bottom of the typical range the dividend futures-based model would place it assuming investors are focused on the current quarter of 2026-Q4 in setting stock prices.
With bulls spooked by the sudden rapid deflation of some of the biggest companies in the AI tech sector after their earnings outlook shifted to be worst than expected, we can expect more outsize reactions as other companies report their earnings in the next few weeks. How stock prices will react will depend greatly on what new information investors will need to absorb from the newstreams. Much like they had to do with the market moving headlines from the final trading week of October 2026….
- Monday, 26 October 2026
-
- Signs and portents for the U.S. economy:
- US retailers face record holiday delivery prices from surcharges tied to costlier diesel
- Oil slides over 2% as traders weigh Saudi attack risks, demand destruction
- US airlines favor higher fares over fuller planes as fuel costs squeeze profits
- Microsoft to Trim Workforce with Buyout Offers for 60,000 Staff
- Fed minions expected to leave interest rates unchanged this week:
- Some growth signs developing in China:
- Bigger trouble, wage-price inflation spiral developing in Japan:
- Japanese companies compensate users as cyberattacks buffet economy
- Japan auto union group looks beyond inflation-linked pay hikes for 2027 talks
- Bigger trouble developing in Eurozone:
- Euro zone firms find it harder to get credit, ECB survey shows
- EU Climbs Escalation Ladder With Beijing, Plans Wider Curbs On Chinese Imports
- Wall Street ends higher as AI capex fears pause, Fed decision looms
- Tuesday, 27 October 2026
-
- Signs and portents for the U.S. economy:
- AI investment boom powers US business spending on equipment in September
- Oil rises as hopes for diplomacy offset impact of renewed Houthi attacks
- OPEC+ oil producers set to keep output targets steady at Sunday meeting, sources say
- US energy firms to produce record natgas in 2026 as global demand soars
- Hold or sell? High Treasury yields spur US banks to rethink bond portfolios
- US new home sales fall in September; median house price drops from year ago
- Fed minions hear speculation in media about their next moves:
- Fed expected to hold rates steady, but Warsh may point way to more hikes
- Fed rate hikes are coming, but not this week: CNBC survey
- Bigger trouble, mixed growth signs developing in China:
- In China, the AI bubble has already burst
- China’s industrial profit growth picks up amid deepening economic divergence
- Former BOJ chief minion super excited for more interest rate hikes in Japan, JapanGov minion standing by to keep Japan’s currency from collapsing:
- Ex-BOJ chief Kuroda backs more rate hikes, his former deputy urges caution
- Japan stands ready to take decisive action in currency market, finance minister says
- Bigger trouble developing in Eurozone:
- Interview. France must ‘cure ourselves’ without more spending, says finance minister
- Euro zone mortgage demand falls as rates rise, ECB survey shows
- Euro zone lending holds up even as banks tighten access
- Wall Street ends higher ahead of FOMC rate decision, big tech earnings
- Wednesday, 28 October 2026
-
- Signs and portents for the U.S. economy:
- Mortgage rates fell for the second straight week, but more borrowers still opted for riskier loans
- Oil rises over 1% after Saudi Arabian refinery attack reignites supply risk
- US goods trade deficit widens as AI-related demand pushes imports to record high
- Walmart cuts holiday meal basket price to $3.50 per person
- As expected, Fed minions leave U.S. interest rates unchanged, threaten future hikes:
- Warsh to attend Fed jobs and productivity task force hearing to refine views
- Fed officials not aligned on weight of financial conditions
- Fed’s Warsh says US economy not running too hot
- Bigger trouble, stimulus developing in China:
- China’s new export curbs draw a line around its AI crown jewels
- Why China is desperate to ship cars outside of the country
- Wall Street advances for the third consecutive session after the Fed keeps rates unchanged
- Thursday, 29 October 2026
-
- Signs and portents for the U.S. economy:
- US inflation heats up in September; consumer spending rises
- AI-related investment, consumers likely boosted US economic growth in third quarter
- Oil falls as diplomacy hopes outweigh Middle East escalation fears
- US weekly jobless claims hover near 57-year lows
- Fed minions thinking about their balance sheet:
- Bigger trouble developing in China:
- Job hunting chief ECB minion to quit ECB early as ECB minions skip rate hike for now with plan to hike Eurozone interest rates later:
- ECB flags December hike but sees yield rise hitting growth
- Nasdaq sheds 1.4% as Alphabet’s historic drop rattles the markets, U.S. stocks suffer
- Friday, 30 October 2026
-
- Signs and portents for the U.S. economy:
- Fed minions say inflation bad enough to justify rate hikes, but not until December 2026:
- BOJ minions claim success in hitting their inflation target, thinking about more rate hikes later in year to contain it:
- BOJ holds rates as underlying inflation aligns with 2% target for first time since 2013
- Bigger trouble developing in Eurozone:
- S&P 500 ends week lower as AI concerns fuel rotation into defensive sectors
- Amazon burns cash, Intel flags weak PC demand as AI boom’s costs ripple across markets
- Intel on course for worst day ever, triggers global chip rout
The CME Group’s FedWatch Tool projections were unchanged. It still anticipates the Fed will next act to hike the Federal Funds Rate by a quarter point on 9 December (2026-Q4). Looking further forward in time, the FedWatch tool projects the Fed will hike this interest rate by a quarter percent on 17 March (2027-Q1). After that, the FedWatch Tool anticipates one more rate hike in 2027, coming when the Fed meets on 15 September (2027-Q3).
The Bureau of Economic Analysis reported its initial estimate for annualized real GDP growth during 2026-Q3 is +3.4%, just a bit lower than the +3.5% growth projected by the Atlanta Fed’s GDPNow tool a week before.
The GDPNow tool has shifted forward to projecting the current quarter of 2026-Q4′s inflation-adjusted economic growth rate, with its first estimate for the quarter coming in at 3.2%.
Image credit: Microsoft Copilot Designer. Prompt: “An editorial cartoon of a Wall Street bull taking cover under a table as a few balloons labeled ‘AI’ begin to pop while a smiling bear loads a dart labeled ‘COSTS’ into a blowgun”.
Source: https://politicalcalculations.blogspot.com/2026/11/s-500-falls-as-investors-get-spooked-by.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.



